Reduction of the expansion rate of small abdominal aortic aneurysms by treatment with roxithromycin;Haemning af små abdominale aortaaneurismers ekspansion med roxithromycin

Ugeskrift for Laeger

Volumn 164, Issue 50, 2002, Pages 5916-5919

  Vammen, Sten ^a   Lindholt, Jes S ^b   Østergaard, Lars J ^b   Fasting, Helge ^b   Henneberg, Eskild W ^b  

^a NONE   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; MACROLIDE; PLACEBO; ROXITHROMYCIN;

ABDOMINAL AORTA ANEURYSM; AGED; ANTIBIOTIC THERAPY; AORTA ANEURYSM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; AORTIC ANEURYSM, ABDOMINAL; FOLLOW-UP STUDIES; HUMANS; MALE; RECURRENCE; RISK FACTORS; ROXITHROMYCIN; TREATMENT OUTCOME;

EID: 0037049414     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Vammen S. Prevention and Treatment of Abdominal Aortic Aneurysms (ph.d.-afhandling). Århus: Aarhus University Press, 2002.
2. Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman MR, Manninen V et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273-8.
3. Lindholt JS, Juul S, Vammen S, Lind I, Fasting H, Henneberg EW. IgA antibodies against Chlamydia pneumoniae are associated to expansion of abdominal aortic aneurysms. Br J Surg 1999; 86: 634-8.
4. Lindholt JS. Considerations and Experiences of Screening for Abdominal Aortic Aneurysms (ph.d.-afhandling). København: FADL's Forlag, 1998.
5. Lindholt JS, Vammen S, Fasting H, Henneberg EW. Psychological consequences of screening for abdominal aortic aneurysm and conservative treatment of small AAA. Eur J Vasc Endovasc Surg 2000; 20: 79-83.
6. Thomas PR, Shaw JC, Ashton HA, Kay DN, Scott RA. Accuracy of ultrasound in a screening programme for abdominal aortic aneurysms. J Med Screen 1994; 1: 3-6.
7. Østergaard L, Sørensen HT, Lindholt JS, Sørensen TE, Pedersen L, Eriksen T et al. Risk of hospitalisation for cardiovascular disease after use of macrolides and penicillins: A comparative prospective cohort study. J Infect Dis 2001; 183: 1625-30.
8. Gieffers J, Fullgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001; 103: 351-6.
9. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451-61.
10. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis. BMJ 2000; 321: 208-13.